CVS Health (CVS) Tops Q2 EPS by 75c; raises guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads gains as SpaceX, Super Micro results improve AI appetite
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- AI bubble about to burst? Not yet, Yardeni says
- SpaceX tops Q3 estimates as revenue surges 161% on Starlink, AI compute expansion
Tweet
Share
E-mail
Get Alerts CVS Hot Sheet
Price: $93.94 -0.85%
EPS Growth %: +3.1%
Financial Fact:
Cost of revenues: 37.12B
Today's EPS Names:
OMID, BCML, CZNC, More
EPS Growth %: +3.1%
Financial Fact:
Cost of revenues: 37.12B
Today's EPS Names:
OMID, BCML, CZNC, More
Join SI Premium – FREE
CVS Health (NYSE: CVS) reported Q2 EPS of $2.58, $0.75 better than the analyst estimate of $1.83. Revenue for the quarter came in at $106.1 billion versus the consensus estimate of $100.03 billion.
GUIDANCE:
CVS Health sees FY2026 EPS of $7.90-$8.10, versus the consensus of $7.45.
For earnings history and earnings-related data on CVS Health (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Putin's Aide Says War In Ukraine Moving Toward An End - Vesti
- NeOnc expands Abu Dhabi program, schedules FDA meeting for NEO212
- Alphabet shares drop ahead of earnings next week
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
